Skip to main content

Table 1 Frequencies of any diagnosis of COVID-19, entry to critical care and fatal outcome among those eligible for shielding, by eligibility category, up to 18 February 2021

From: Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study

   Diagnosed with COVID-19  
  Not diagnosed with COVID-19 No critical care, non-fatal Critical care, non-fatal Fatal All
All shielding categories 204,703 (96.2%) 6081 (2.9%) 359 (0.2%) 1559 (0.7%) 212,644
Shielding eligibility category
Solid organ transplant 6620 (96.3%) 188 (2.7%) 24 (0.3%) 40 (0.6%) 6872
Specific cancers 25,788 (96.6%) 652 (2.4%) 36 (0.1%) 223 (0.8%) 26,699
Severe respiratory 83,268 (96.2%) 2432 (2.8%) 131 (0.2%) 768 (0.9%) 86,599
Rare diseases 10,673 (96.4%) 300 (2.7%) 14 (0.1%) 85 (0.8%) 11,072
On immunosuppressants 30,796 (96.8%) 866 (2.7%) 42 (0.1%) 103 (0.3%) 31,807
Additional conditions 47,501 (95.8%) 1642 (3.3%) 112 (0.2%) 340 (0.7%) 49,595
  1. Percentages are row percentages
  2. Severe cases are those that entered critical care or were fatal